Role of osteopontin in early brain injury after subarachnoid hemorrhage in rats

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 75-79

  Suzuki, Hidenori ^a   Ayer, Robert ^a,b   Sugawara, Takashi ^a   Chen, Wanqiu ^a   Sozen, Takumi ^a   Hasegawa, Yu ^a   Kanamaru, Kenji ^c   Zhang, John H ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c Suzuka Kaisei Hospital   (Japan)

Author keywords

Blood brain barrier; Brain injury; Osteopontin; Subarachnoid hemorrhage

Indexed keywords

GELATINASE B; I KAPPA B ALPHA; I KAPPA B BETA; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; LAMININ; OSTEOPONTIN; PROTEIN ZO1; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; CONFERENCE PAPER; CONTROLLED STUDY; CONVALESCENCE; ENZYME INHIBITION; MALE; MICROVASCULATURE; NEGATIVE FEEDBACK; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SUBARACHNOID HEMORRHAGE;

EID: 85052609988     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0353-1_14     Document Type: Conference Paper

References (19)

1. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin. A molecule for all seasons. Q J Med. 2002;95:3-13.
2. Chabas D, Baranzini SE, Mitchell D, Bernard CCA, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001;294:1731-5.
3. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001;107:1055-61.
4. Kang W-S, Choi J-S, Shin Y-J, Kim H-Y, Cha J-H, Lee J-Y, et al. Differential regulation of osteopontin receptors, CD44 and the av and b3 integrin subunits, in the rat hippocampus following transient forebrain ischemia. Brain Res. 2008;1228:208-16.
5. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, et al. Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab. 2005;25:217-25.
6. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 2006;129:1426-37.
7. Sugwara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods. 2007;167:327-34.
8. Ayer RE, Sugawara T, Chen W, Tong W, Zhang JH. Melatonin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res. 2008;44:197-204.
9. Allen RM, Uban KA, Atwood EM, Albeck DS, Yamamoto DJ. Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats. Pharmacol Biochem Behav. 2007;88: 82-8.
10. Yatsushige H, Ostrowski RP, Tsubokawa T, Colohan A, Zhang JH. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J Neurosci Res. 2007;85:1436-48.
11. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:317-30.
12. Sehba FA, Mostafa G, Knopman J, Friedrich Jr. V., Bederson JB. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg. 2004;101:633-40.
13. Fujimoto M, Takagi Y, Aoki T, Hayase M, Marumo T, Gomi M, et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab. 2008;28:1674-85.
14. Bond M, Chase AJ, Baker AH, Newby AC. Inhibition of transcription factor NF-kB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res. 2001;50:556-65.
15. Trescher K, Bernecker O, Fellner B, Gyongyosi M, Schafer R, Aharinejad S, et al. Inflammation and postinfarct remodeling: Overexpression of IkB prevents ventricular dilation via increasing TIMP levels. Cardiovasc Res. 2006;69:746-54.
16. Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1b. J Biol Chem. 279:39513-9.
17. Arafat HA, Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, et al. Osteopontin protects the islets and b-cells from interleukin-1b-mediated cytotoxicity through negative feedback regulation of nitric oxide. Endocrinology 2007;148:575-84.
18. Wu CY, Hsieh HL, Jou MJ, Yang CM. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem. 2004;90:1477-88.
19. Lo EH. A new penumbra: Transitioning from injury into repair after stroke. Nat Med. 2008;14:497-500.